You are here

diabetes

Medtronic Is Sweet on EOFlow

Medtronic Is Sweet on EOFlow

Medical Devices and Diagnostics Industry

Flag link:

What you need to know about pharma, PBM execs testifying on insulin prices

What you need to know about pharma, PBM execs testifying on insulin prices

Medical Marketing and Media

Flag link:

No Layoffs Here: Senseonics to Expand Sales Team

No Layoffs Here: Senseonics to Expand Sales Team

Medical Devices and Diagnostics Industry

continuous glucose monitoring

Flag link:

Medtronic diabetes warning letter lifted by FDA

Medtronic diabetes warning letter lifted by FDA

Medtech Dive

Flag link:

Medtronic wins FDA approval for long-delayed MiniMed 780G insulin pump

Medtronic wins FDA approval for long-delayed MiniMed 780G insulin pump

Medtech Dive

Flag link:

See you later, Baqsimi: Lilly sells low blood sugar rescue treatment to Amphastar for $500M-plus

See you later, Baqsimi: Lilly sells low blood sugar rescue treatment to Amphastar for $500M-plus

Fierce Pharma

Flag link:

What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take

What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take

Fierce Pharma

Flag link:

Novo’s latest deal targets cell therapy for diabetes, obesity

Novo’s latest deal targets cell therapy for diabetes, obesity

BioPharma Dive

Aspect Biosystems

Flag link:

Bernie Sanders weighs Senate hearing for largest insulin makers

Bernie Sanders weighs Senate hearing for largest insulin makers

Seeking Alpha

Flag link:

Abbott’s CGM Readers Face Class I Recall Over Lithium-ion Battery Issues

Abbott’s CGM Readers Face Class I Recall Over Lithium-ion Battery Issues

Medical Devices and Diagnostics Industry

FreeStyle Libre

Flag link:

Abbott glucose monitor readers could catch fire, FDA warns in recall notice

Abbott glucose monitor readers could catch fire, FDA warns in recall notice

Stat

product recalls

blood glucose monitoring

Flag link:

Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes

Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes

Xtalks

Flag link:

Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market

Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market

Motley Fool

Flag link:

Diabesity drugs and their free ‘contract sales force’

Diabesity drugs and their free ‘contract sales force’

Medical Marketing and Media

Flag link:

Biomea goes for $125M offering after early diabetes data nearly doubled stock price

Biomea goes for $125M offering after early diabetes data nearly doubled stock price

Endpoints

clinical trials

Flag link:

Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality

Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality

Endpoints

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries

Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries

Fierce Pharma

clinical trials

Flag link:

The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win

The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win

Investors Business Daily

Flag link:

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

CP Wire

PTC Therapeutics

Flag link:

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

PTC Therapeutics

Flag link:

Pages